Flexion Therapeutics, Inc. Proceeds from Common Stock Issued
Flexion Therapeutics, Inc. reported Proceeds from Common Stock Issued of $1.70 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-11-12
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-06-30 was $0.00.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-03-31 was $1.70M.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2020 was $97.29M.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2016 was $147.89M.
- Flexion Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2014 was $162.14M.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed | Proceeds from Issuance of Common Stock 77 month |
|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $1.70M 10-Q · filed 2021-11-12 | $1.70M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.70M 10-Q · filed 2021-08-04 | $1.70M derived: sum of 3 quarters · filed 2021-08-04 | $98.99M derived: sum of 4 quarters · filed 2021-08-04 | ||||
| 2021-03-31 | $1.70M 10-Q · filed 2021-05-12 | $1.70M derived: sum of 2 quarters · filed 2021-05-12 | $98.99M derived: sum of 3 quarters · filed 2021-05-12 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $97.29M derived: sum of 2 quarters · filed 2021-03-10 | $97.29M 10-K · filed 2021-03-10 | |||||
| 2020-09-30 | $97.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $97.29M 10-Q · filed 2020-11-04 | ||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | $97.29M 10-Q · filed 2020-08-05 | ||||||
| 2017-12-31 | $132.67M 8-K · filed 2020-05-20 | |||||||
| 2016-12-31 | $70.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $70.25M derived: sum of 2 quarters · filed 2019-02-28 | $147.89M 10-K · filed 2019-02-28 | $147.89M 10-K · filed 2017-03-10 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $77.64M 10-Q · filed 2017-11-06 | ||||||
| 2016-06-30 | $77.64M 10-Q · filed 2017-08-08 | |||||||
| 2014-12-31 | $92.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $92.62M derived: sum of 2 quarters · filed 2017-03-10 | $92.62M derived: sum of 3 quarters · filed 2017-03-10 | $162.14M 10-K · filed 2017-03-10 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $69.52M 10-Q · filed 2015-11-09 | |||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $69.52M 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | $69.52M 10-Q · filed 2015-05-08 | $69.54M 10-Q · filed 2014-05-12 | ||||||
| 2008-12-31 | $20.75K 10-K · filed 2015-03-24 |